Anita Dushyanth
Stock Analyst at Berenberg
(2.72)
# 2,087
Out of 4,984 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $18.10 | +10.50% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.28 | +296.34% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $2.90 | +41,279.31% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $26.07 | +256.73% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $18.10
Upside: +10.50%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.28
Upside: +296.34%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $2.90
Upside: +41,279.31%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $26.07
Upside: +256.73%